alvimopan: Clinical Trials

5 trials of alvimopan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Terminated 2

Follow alvimopan: new trials by email Literature Review of alvimopan trials Research Report on alvimopan

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2 RCT of Alvimopan vs. Placebo After CRS/HIPEC
Alvimopan, Placebo - Ileus
Phase 2TerminatedUniversity of California, San Diego842018-03-082021-08-18
Entereg Laparoscopic Colon Resection Study
Entereg, placebo - Laparoscopic Colonic Resection
Phase 2CompletedHartford Hospital1352010-11-012015-08-26
Clinical Evaluation Of Alvimopan (SB767905) On Constipation And Related Symptoms Associated With Opioid
alvimopan, Placebo, Alvimopan 0.5 mg/day - Cancer, Constipation
Phase 2TerminatedCubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)212006-04-012015-09-02
Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
alvimopan, placebo - Cancer, Bowel Dysfunction
Phase 2CompletedCubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)672004-09-012015-09-02
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
alvimopan, placebo - Constipation, Bowel Dysfunction
Phase 2CompletedCubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2332003-10-012017-08-30

Conditions studied

Constipation (3)  ·  Intestinal Diseases (2)  ·  Neoplasms (2)  ·  Cancer Pain (1)  ·  Ileus (1)  ·  Opioid-Induced Constipation (1)  ·  Peritoneal Neoplasms (1)

Sponsors

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (3)  ·  Hartford Hospital (1)  ·  University of California, San Diego (1)

Countries

United States (4)  ·  Canada (2)  ·  Finland (2)  ·  France (2)  ·  Hong Kong (2)  ·  New Zealand (2)  ·  Pakistan (2)  ·  Peru (2)  ·  Poland (2)  ·  Portugal (2)  ·  Russia (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Australia (1)

Top investigators

Joel M Baumgartner, MD, MAS (1)

Results publications

PMID 36102565